Bluefin Biomedicine, Inc.
Clinical trials sponsored by Bluefin Biomedicine, Inc., explained in plain language.
-
New hope for painful skin condition: drug trial targets stubborn HS
Disease control Recruiting nowThis study tests a new drug called BFB759 for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. About 210 adults will receive either BFB759 or a placebo to see if the drug reduces the number of painful bumps an…
Phase: PHASE2, PHASE3 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibody aims to calm eczema Flare-Ups from the inside
Disease control Recruiting nowThis study tests an experimental drug called BFB759, a lab-made antibody that blocks several inflammatory signals at once. Researchers want to see if it can reduce redness, swelling, and itching in adults with moderate-to-severe eczema that hasn't improved with creams. About 225 …
Phase: PHASE2 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC